Evoke Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
March 04, 2021 16:05 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases,...
Evoke Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares
January 20, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases,...
Evoke Pharma Announces Pricing of Public Offering of Common Stock
January 13, 2021 20:03 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases,...
Evoke Pharma Announces Proposed Public Offering of Common Stock
January 13, 2021 16:02 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases,...
Evoke Pharma Announces Positive Findings from GIMOTI™ Market Research Study
January 13, 2021 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (“Evoke” or the “Company”) (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal...
Evoke Pharma Reports Third Quarter 2020 Financial Results
November 10, 2020 08:30 ET
|
Evoke Pharma, Inc.
Gimoti™ commercial launch underway SOLANA BEACH, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for...
Evoke and EVERSANA Announce Commercial Launch of Gimoti™
October 26, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif. and CHICAGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases,...
Evoke Pharma to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
September 09, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma and EVERSANA Announce the Appointment of Christopher Quesenberry as Chief Commercial Officer for Gimoti™
August 25, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and...
Evoke Pharma Reports Second Quarter 2020 Financial Results
August 06, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...